Loading clinical trials...
Loading clinical trials...
A Phase 2, Open-Label, Multi-Center, Dose Finding Study of the Safety, Pharmacodynamics, and Pharmacokinetics of Peginesatide for the Maintenance Treatment of Anemia in Hemodialysis Patients Previously Treated With Epoetin
Conditions
Interventions
peginesatide
peginesatide
+4 more
Locations
15
Bulgaria
Research Facility
Burgas, Bulgaria
Research Facility
Pleven, Bulgaria
Research Facility
Plovdiv, Bulgaria
Research Facility
Rousse, Bulgaria
Research Facility
Sofia, Bulgaria
Research Facility
Sofia, Bulgaria
Start Date
December 1, 2006
Primary Completion Date
April 1, 2008
Completion Date
April 1, 2008
Last Updated
June 29, 2012
NCT07241390
NCT05012111
NCT03520647
NCT06926660
NCT06717698
NCT05447442
Lead Sponsor
Affymax
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions